Clenio SRL
Clenio reported revenue of 0 € for the 2025 financial year (annual accounts filed with the NBB on 13 Jul 2026).
The score of Clenio shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2023 → 2025: Equity +95 % Total assets +47 %
Accounts of the company itself (not consolidated).
The full file covers 3 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Clenio's annual accounts
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Revenue | 0 € | ||
| Net result | 219,453 € | ||
| Equity | 703,869 € | ||
| Cash | 70,016 € | ||
| EBITDA | 160,414 € | ||
| Total assets | 884,617 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 13 Jul 2026
- Year ended 31 Dec 2024filed on 30 Jul 2025
- Year ended 31 Dec 2023filed on 17 Jul 2024
Clenio's financial analysis
- Solvency79.6%sector median: 58.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Clenio
Clenio's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0797.066.222
- VAT number
- BE0797066222
- Peppol
- Registered · 0208:0797066222 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 12 Jan 2023
- Registered office
- 4020 Liège
- Latest accounts
- 2025 · filed on 13 Jul 2026
- Activity
- Research and experimental development on biotechnology (NACE 72101)
Clenio (SRL) has been based in Liège since 2023, active in: research and experimental development on biotechnology. For 2025, it reports revenue of 0 €, a net profit of 219,453 € and equity of 703,869 €. Its solvency stands at 79.6%, above the median of its sector (58.2%).
Companies similar to Clenio
Companies in the same business, of comparable size and area, outside its group.
- Focus Clinical Consultancy Research and experimental development on natural sciences and engineering Bilzen-Hoeselt · balance sheet 571,822 €
- GeneriX Business and other management consultancy activities Seraing · balance sheet €1.00m
- Opis Belgium Business and other management consultancy activities Brussels · balance sheet 630,008 €
- FLIR Belgium Other business support service activities n.e.c. Brecht · balance sheet €1.94m
- Biostrand Research and experimental development on natural sciences and engineering Diepenbeek · balance sheet 804,186 €
- 3iDea Research and experimental development on natural sciences and engineering Beernem · balance sheet 253,951 €
- Teknostix Business and other management consultancy activities Diepenbeek · balance sheet 904,771 €
- Vetapharma Belgium Business and other management consultancy activities Charleroi · balance sheet €2.23m
Frequently asked questions about Clenio
What is the revenue of Clenio?
According to the 2025 annual accounts filed with the NBB, the revenue of Clenio amounts to 0 €.
What is the VAT number of Clenio?
In Belgium, the VAT number is the company number prefixed with BE: BE0797066222 for Clenio, if the company is VAT-registered. Its company number (CBE) is 0797.066.222.
Where is the registered office of Clenio?
According to the CBE register, the registered office of Clenio is in 4020 Liège.
What is the equity of Clenio?
At the close of the 2025 financial year, the equity of Clenio amounts to 703,869 €, a solvency of 79.6% of total assets.
Who manages Clenio?
The register lists 4 active mandates at Clenio. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Clenio
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →